Gene Query: SNAPC1

Dataset Description Geneva Score
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 149.25
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 89.95
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 73.6
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 56.0
A sister of NANOG regulates genes expressed in pre-implantation human development 54.93
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 53.88
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 52.56
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 49.52
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 39.19
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 37.53
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 37.53
Effect of mitochondria deficiency on senescence-associated gene expression 37.14
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 35.36
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 34.12
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 33.31
A role for ZNF598 in post-transcriptional gene regulation 32.2
Nucleoporin-mediated regulation of cell identity genes 32.17
RNA-Seq analysis of breast cancer cells after shikonin treatment 32.14
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 31.87
Overexpression and knockdown experiment for circCSNK1G3 31.64
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 30.69
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 30.55
MYCi975 regulates MYC target genes 29.92
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 29.83
Functional role of SLIT2 and ROBO1 in trophoblasts 29.61
Spliceosomal disruption of the non-canonical BAF complex in cancer 29.29
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 28.62
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 28.57
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 27.03
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 25.91
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 25.64
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 25.64
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 24.96
Metastasis in triple-negative breast cancer 24.28
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 24.28
hTERT promotes cell adhesion and migration independent of telomerase activity 24.24
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 24.13
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 23.93
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 23.17
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 22.79
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 22.47
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 22.45
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 22.41
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 22.41
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 22.16
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 22.14
Molecular Mechanisms of Endothelial Hyperpermeability 21.51
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 21.41
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 21.41
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 21.41
Selective suppression of endothelial cytokine production by progesterone receptor 21.41
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 21.35
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 21.35
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 21.26
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 21.26
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 21.2
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 20.8
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 20.69
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 20.66
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 20.21
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 19.86
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 19.52
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 19.35
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 19.01
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 18.67
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 18.55
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 18.55
p53 activity results in DNA replication fork processivity 18.19
Disruption of the exocyst induces podocyte loss and dysfunction 17.96
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 17.4
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 17.34
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 17.34
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 17.05
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 17.0
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 16.94
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 16.87
Exogenous rescue of KLHL9 in SF210 cell line 16.83
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 16.79
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 16.79
Fbxo32 mediated gene expression program underlies EMT and metastasis 16.74
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 16.38
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 16.35
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 16.34
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 15.92
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 15.75
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 15.75
WRN knockout effects upon gene expression in SW48 and OVK18 15.46
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 15.39
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 15.14
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  15.01
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 14.97
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 14.93
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 14.91
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 14.79
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 14.36
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 14.12
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 14.05
Paxillin regulates genomic networks in prostate cancer [PC3] 14.02
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 14.0
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 13.9
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 13.7
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 13.7
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 13.69
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 13.66
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 13.57
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 13.54
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 13.54
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 13.43
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 13.41
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 13.34
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 13.3
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 13.23
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 13.04
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 12.87
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 12.85
Analysis of transcriptional regulation by Myt1 and Myt1l 12.85
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 12.83
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 12.81
Genome-wide analysis of Dengue virus 2 infected cells 12.78
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 12.59
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 12.5
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.41
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 12.23
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 12.16
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 12.16
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 12.04
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 12.04
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 12.04
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 12.03
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 12.03
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.95
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 11.82
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 11.82
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 11.64
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 11.64
Transcriptome analysis of Zika infected neural stem cells 11.64
Zika infected neural stem cells 11.64
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 11.56
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 11.29
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 11.2
Transcriptome analysis in Neobractatin treated cells 11.15
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 11.14
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 11.02
ARID1A and ARID1B loss in HCT116 and TOV21G cells 10.93
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 10.92
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 10.91
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 10.91
Electronic cigarettes 10.84
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.78
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 10.62
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.43
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 10.36
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.35
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 10.27
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 10.27
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.27
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 10.23
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 10.19
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 10.19
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 9.93
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 9.75
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.69
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 9.62
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 9.44
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 9.39
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 9.36
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 9.26
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.22
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 9.14
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 9.07
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.07
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.07
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 9.01
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 8.96
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 8.93
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.88
Functional role of CPPED1 in trophoblasts. 8.87
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 8.74
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 8.59
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 8.55
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 8.51
RNA-seq analysis to identify the genes regulated by p53-SET interplay 8.49
Real-time observation of light-controlled transcription in living cells 8.49
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 8.4
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 8.37
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 8.35
Transcriptome analysis of kidney organoids 8.31
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 8.29
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 8.24
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 8.23
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 8.18
Inhibition of TNBC metastasis by Gpx1 8.15
CD73 knockdown effect in pancreatic cancer cell lines 8.08
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 8.06
Regulation of protein translation during mitosis 8.01
Transcriptomic analysis of human tonsillar TFH subsets 7.96
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 7.94
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 7.87
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 7.8
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.71
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 7.71
Gene expression in PANC1 cells treated with Rakicidin 7.7
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 7.69
Neonatal and adult human testis defined at the single-cell level 7.65
STRIPAK directs PP2A activity to promote oncogenic transformation 7.64
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 7.61
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 7.61
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 7.56
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 7.49
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.45
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 7.39
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.31
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.22
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.22
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.16
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.16
Genetic-to-epigenetic Therapy for Pancreatic Cancer 7.14
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 7.13
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 7.12
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.09
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.09
Function and hormonal regulation of GATA3 in human first trimester placentation 7.09
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 7.08
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 7.08
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 7.06
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 7.05
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.03
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 6.88
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 6.74
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 6.73
Generation of trichogenic adipose-derived stem cells by expression of three factors 6.72
Investigation about fibroblasts of different origins in culture 6.68
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.66
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.64
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.64
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.63
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 6.62
RNA sequencing of human mammary epithelial cells 6.53
RNA-seq of MDA-MB-231 cells with TET1 knockout 6.5
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.49
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.49
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 6.39
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.38
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.37
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.37
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 6.36
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 6.35
Proteomics identifies a marker signature of MAPKi resistance in melanoma 6.33
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 6.31
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 6.29
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.23
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 6.14
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 6.14
Transcriptome-wide response to synthetic chromatin protein PcTF 6.14
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.14
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 5.97
ADAR1-editing of cellular and measles virus-derived duplex RNA 5.97
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 5.95
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.92
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.92
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.92
Statins modulate endothelial transcriptional profile by inhibiting EZH2 5.88
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.87
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.83
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.83
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.8
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.8
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 5.79
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.75
ARID1A regulates condensin II distribution and chromosomal partition 5.73
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 5.73
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.68
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.64
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.64
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 5.64
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 5.63
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 5.63
SNHG5 siRNA knock down in HCT116 cells 5.63
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.62
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.62
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 5.57
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.56
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.55
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.53
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 5.51
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 5.5
RNA-seq of young and quiescent MRC-5 human fibroblasts 5.5
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 5.48
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 5.48
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.43
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 5.42
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 5.35
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 5.35
Global Mapping of Human RNA-RNA Interactions 5.34
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 5.28
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.27
Transcriptomic analyssis following EHMT1/2 inhibition 5.27
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.24
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 5.23
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 5.16
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 5.14
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.12
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 5.11
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 5.05
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.04
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 5.02
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 5.02
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.96
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.96
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 4.96
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 4.95
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 4.9
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.9
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.86
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.86
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 4.86
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 4.86
scRNASeq analysis of cycling cardiomyocytes 4.84
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.83
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.8
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.7
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.68
circRNA-sequencing 4.65
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.64
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 4.63
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 4.62
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 4.62
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 4.6
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 4.57
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 4.54
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 4.52
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.51
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.46
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.42
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.41
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 4.37
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 4.34
Endothelial gene expression analysis 4.32
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.32
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.26
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 4.23
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 4.2
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 4.18
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 4.18
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.18
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.14
Gene expression profile in breast cancer cells 4.14
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 4.13
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.12
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.1
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 4.07
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 4.07
Cell responses to dysregulated VZV-induced cell-cell fusion 4.07
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 4.06
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.01
Single-cell analysis of adult human ovary using 10X genomics 4.01
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.99
miR-93 Targets in Human Endothelial Cells 3.98
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.96
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.96
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 3.89
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 3.83
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.79
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.78
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 3.76
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 3.74
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.73
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.69
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.67
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 3.65
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.61
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.61
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.6
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.6
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 3.53
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.52
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.48
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.47
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.44
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 3.39
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.28
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.25
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.17
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.17
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.14
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 3.02
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.01
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.98
Generation of KRAS signatures using immortalized isogenic lung cells. 2.91
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.91
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.91
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.86
Mapping interactions for the TNIP2 hub protein 2.82
6mer seed toxicity in tumour suppressive microRNAs 2.7
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.65
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 2.6
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.56
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.52
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 2.49
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.4
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.4
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.34
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.28
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.22
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.17
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.13
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.11
HBEC-shp53-PCHD7 2.11
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.07
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.01
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 2.01
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 2.01
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.97
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.95
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.95
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.91
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 1.9
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.89
Copper Regulation of HIF-1 Transcription Activity 1.89
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.88
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.86
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.75
Anti-inflammatory effect of indoleacrylic acid (IA) 1.74
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.73
Regulation of poly(A) tail and translation during the somatic cell cycle 1.73
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.72
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.7
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.7
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.7
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.65
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 1.59
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.56
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.53
Discovering human diabetes-risk gene function with genetics and physiological assays 1.52
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.5
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.39
Differential gene expression of human melanoma cells [RNA-seq] 1.38
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.38
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.37
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.36
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.34
CDK12 mediated transcriptional regulation in U2OS cells 1.32
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 1.29
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 1.29
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.29
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.25
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.22
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.22
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.21
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.12
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.11
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.09
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.08
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.01
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.95
The cohesin complex prevents Myc-induced replication stress 0.93
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.92
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.92
Transcriptional landscape changes during human embryonic stem cell derivation 0.85
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.82
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 0.81
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.81
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.76
Regulation of hypoxia-inducible factor activity by ZMYND8 0.73
Ribosome profiling upon inhibition of eIF4A 0.73
siRNA-mediated knockdown 0.69
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.68
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.66
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.61
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.56
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.49
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.48
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.45
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.39
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.39
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.39
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.38
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.33
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.33
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.33
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.29
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.27
High-resolution comparative analysis of great ape genomes 0.26
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 0.25
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.24
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.21
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.21
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.17
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.14
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.13
Gene expression analysis of breast cancer cell-lines 0.13
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.12
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.11
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.08
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.08
Genome-wide analysis of the Integrator complex 0.08
Genome-wide analysis of the Integrator complex (HTS) 0.08
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.03
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation